Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-23-003073

Director sold 3,200 shares at $30.00 ($96,000)

  • Director acquired 7,867 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Waddill William D. Director 2023-01-09 Sale −3,200 $30.00 $96,000 28,950 D
Waddill William D. Director 2023-01-10 Grant or award +7,867 36,817 D
Derivatives
Waddill William D. Director 2023-01-10 Grant or award · Common Stock +4,593 4,593 D
Open-market sales · 3,200 sh · avg $30.00 · $96,000
Loading xslF345X03/doc4.xml…